Vaccine against COVID-19 or against SARS-CoV-2 infection?

  • Rieske P
N/ACitations
Citations of this article
19Readers
Mendeley users who have this article in their library.

Abstract

Article offers analysis of main aspects of SARS-CoV-2/COVID-19 vaccination (severe acute respiratory syndrome coronavirus 2/COVID-19-Coronavirus Disease 2019). Optimal vaccine should protect not only against disease COVID-19 (symptoms), but also against SARS-CoV-2 infection (spreading disease). However, this kind of vaccine - showing highest safety level is extremely difficult to get. Several additional SARS-CoV-2/COVID-19 vaccination issues were addressed in article. For example: serological passports, herd immunity, clinical trials, and role of antibodies and T cells crossreactivities. Article discusses some issues related to vaccination responsibilities.

Cite

CITATION STYLE

APA

Rieske, P. (2020). Vaccine against COVID-19 or against SARS-CoV-2 infection? Alergologia Polska - Polish Journal of Allergology, 7(3), 131–145. https://doi.org/10.5114/pja.2020.97913

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free